Lüscher, Bernhard Meier, Stephan Windecker, Peter Jüni Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction 15 RCT 2012 A
Trang 1Can thiệp cấp cứu động mạch vành: lựa chọn stent trần hay stent phủ thuốc
-
TS Nguyễn Cửu Lợi Trung tâm Tim mạch – Bệnh viện Trung Ương Huế
Trang 3Maarten A Vink, Maurits T Dirksen, Maarten J Suttorp, Jan G.P Tijssen, Jeroen van Etten, Mark S Patterson, Ton Slagboom, Ferdinand Kiemeneij, Gerrit J Laarman
• Randomly assigned 619 patients presenting with STEMI to a paclitaxel-eluting stent (PES) or the similar BMS
• The primary end point was the composite of cardiac death,
recurrent myocardial infarction, or TLR
• Follow-up at 5 years
Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation [ PASSION ]
Trang 6Conclusions
In the present analysis of PES compared with BMS in primary
percutaneous coronary intervention for STEMI:
- No significant difference in major adverse cardiac events
was observed
- In addition, no difference in the incidence of definite or
probable ST was seen, although very late ST was almost
exclusively seen after the use of PES
J Am Coll Cardiol Intv 2011;4:24–9
Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation [PASSION]
Trang 9Ev
Trang 12- 3980 (63.2%) DES (99% PES & SES)
- 2318 (36.8%) BMS
Trang 15Bindu Kalesan, Thomas Pilgrim, Katja Heinimann, Lorenz Räber, Giulio G Stefanini, Marco Valgimigli, Bruno R da Costa, François Mach, Thomas F Lüscher, Bernhard Meier, Stephan Windecker, Peter Jüni
Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction (15 RCT)
2012 Apr;33(8):977-87
Trang 16Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction (cont’)
Overall
Year 1
Subsequent year
Trang 17Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction (cont’)
Overall
Year 1
Subsequent year
Trang 18Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction (cont’)
Trang 19Bindu Kalesan, Thomas Pilgrim, Katja Heinimann, Lorenz Räber, Giulio G Stefanini, Marco Valgimigli, Bruno R da Costa, François Mach, Thomas F Lüscher, Bernhard Meier, Stephan Windecker, Peter Jüni
CONCLUSION
An early benefit of early generation DES in primary
PCI for STEMI with a reduction in TVR and a trend
towards less definite ST is offset in subsequent years
by an increased risk of very late ST
Comparison of drug-eluting stents with bare metal stents in patients with ST-segment
elevation myocardial infarction (cont’)
Trang 20Paclitaxel-Eluting Stents versus Bare-Metal Stents
in Acute Myocardial Infarction
Gregg W Stone, M.D., Alexandra J Lansky, M.D., Stuart J Pocock, Ph.D.,
Bernard J Gersh, M.B., Ch.B., D.Phil., George Dangas, M.D., Ph.D., S Chiu Wong, M.D., Bernhard Witzenbichler, M.D., Giulio Guagliumi, M.D., Jan Z Peruga, M.D., Bruce R Brodie, M.D., Dariusz Dudek, M.D., Martin Möckel, M.D., Andrzej Ochala, M.D., Alison Kellock, B.S., Helen Parise, Sc.D., and
Roxana Mehran, M.D for the HORIZONS-AMI Trial Investigators
Trang 21Stone GW et al N Engl J Med 2009;360:1946-1959
Kaplan–Meier Time-to-Event Curves for Primary End Points and Three Components of the Primary Composite Safety End Point
HR, 0.59; 95% CI, 0.43 to 0.83; P=0.002 HR, 1.02; 95% CI, 0.76 to 1.36; P=0.01
HR, 0.97; 95% CI, 0.70 to 1.32; P=0.83 HR, 0.93; 95% CI, 0.59 to 1.47; P=0.77
Trang 28Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients
With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials
Rev Esp Cardiol 2009;62(04):354-64
Raisuke Iijimaa, Robert A Byrnea, Alban Dibraa, Gjin Ndrepepaa, Christian
Spauldingb, Gerrit J Laarmanc, Maurizio Menichellid, Marco Valgimiglie, Emilio
Di Lorenzof, Christoph Kaiserg, Ilkka Tieralah, Julinda Mehillia, Maarten J
Suttorpi, Roberto Violinid, Albert Schömiga, Adnan Kastratia
Trang 29Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment
Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials
Rev Esp Cardiol 2009;62(04):354-64
Trang 30Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment
Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials
Rev Esp Cardiol 2009;62(04):354-64
Trang 31Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment
Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials
Rev Esp Cardiol 2009;62(04):354-64
Trang 32Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment
Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials
Rev Esp Cardiol 2009;62(04):354-64
CONCLUSIONS
In conclusion, use of DES in diabetic patients
undergoing primary stenting for STEMI reduces the
need for repeat intervention without increasing the
rate of thrombosis-related events as compared to
BMS
Trang 45HỘI NGHỊ TIM MẠCH CAN THIỆP
26-27/03/2016
TP Huế